REGISTERED NUMBER: 08670361 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST DECEMBER 2025

FOR

LONDON AESTHETIC MEDICINE LTD

Page

Balance Sheet

1

FIXED ASSETS

9,198

11,831

CURRENT ASSETS

251,289

190,856

CREDITORS

Amounts falling due within one year

(229,901

)

(248,775

)

NET CURRENT ASSETS/(LIABILITIES)

21,388

(57,919

)

TOTAL ASSETS LESS CURRENT LIABILITIES

30,586

(46,088

)

CREDITORS

Amounts falling due after more than one year

-

(5,000

)

NET ASSETS/(LIABILITIES)

30,586

(51,088

)

CAPITAL AND RESERVES

30,586

(51,088

)

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

London Aesthetic Medicine Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

08670361

Registered office:

13 Hursley Road

Chandler's Ford

Eastleigh

Hampshire

SO53 2FW

The presentation currency of the financial statements is the Pound Sterling (£).

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 7 (2024 - 10 ) .

3.	OTHER FINANCIAL COMMITMENTS

The total operating lease commitments amounted to £139,683 (2024 : £238,283) of which, an amount of £98,600 (2024 : £98,600) is due within 1 year.

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 24th April 2026 and were signed on its behalf by:

U Gout - Director